Abstract:Background: Schizophrenia is characterized by abnormal perception, thinking, emotions, and behaviors. Cognitive dysfunction is acknowledged as one of the most pivotal symptoms in schizophrenia. In addition to positive or negative symptoms, which had been proposed by Gallhofer in the early 1970s, schizophrenia patients suffered from cognitive impairments as well. Many studies show that there is genetic susceptibility in the first grading kinship of patients with schizophrenia. Patients with schizophrenia have cognitive impairment not only in the acute phase but also in the stable phase. Studies also show that the healthy first-grading relatives of patients with schizophrenia suffer from cognitive defects. However, there is still a lack of studies about the cognitive features of biological parents of those with schizophrenia. In this study, we speculate the biological parents of schizophrenia patients have specific cognitive dysfunction. And we explore the patterns of cognition among both schizophrenia patients and their biological parents using the Chinese version of MATRICS Consensus Cognitive Battery (MCCB). Aims: Cognitive features of patients with schizophrenia might be affected by the cognition mode of patients' biological parents. The dysfunctional cognitive patterns need to be characterized among the patients with schizophrenia and their parents. Methods: We applied the MATRICS Consensus Cognitive Battery (MCCB, a novel measurement tool) to evaluate the cognitive function of 29 first-episode patients with schizophrenia (meeting ICD-10 diagnostic criteria for schizophrenia, aged between 17-45 years old), 58 cases of biological parents of schizophrenia patients (aged between 40-70 years old) and 46 healthy controls (aged between 40-70 years old). Furthermore, we explored the relationship between the cognitive dysfunction in patients with schizophrenia and their biological parents. All data were analyzed using SPSS18.0 statistical software. Results: 1) Male patients with schizophrenia had obvious cognitive defects in six domains of cognitive function as measured by the MCCB (all except the social cognition domain) compared to their male parents. Female patients showed lower ability on both working memory and problem reasoning than their female parents. 2) The significant differences of both working memory and reasoning problems also existed between the patients' fathers and matched healthy controls. 3) Patients' mothers didn't show any significant difference on the problem reasoning domain compared with healthy controls. However, the visual learning domain appeared abnormal in patients' mothers compared with healthy controls. Conclusion: There are six dimensions of cognitive impairments in both first-episode schizophrenia patients and their biological parents. Compared with healthy controls, patients' biological parents have conspicuous dysfunction in domains of working memory, problem reasoning and visual learning as well. Further study is needed to explore the underlying mechanisms of similar cognitive dysfunction between first-episode schizophrenia patients and their biological parents.

Psychosocial Functioning and Cognitive Deficits Are Not Associated with Membrane-Bound Catechol-O-Methyltransferase Deoxyribonucleic Acid Methylation in Siblings of Patients with Schizophrenia

Genetic Study of Neurocognitive Function in First-Episode Schizophrenia

Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives

Relationship of cognitive measures to mRNA levels in lymphocytes from patients with schizophrenia and controls

Morphological Changes in Gray Matter Volume Correlate with Catechol-O-methyl Transferase Gene Val158Met Polymorphism in First-Episode Treatment-Naïve Patients with Schizophrenia

Further evidence of transmission disequilibrium of the catechol-O-methyl transferase (COMT) gene in schizophrenia in a Chinese population

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression.

Association Analysis of the Catechol‐o‐methyltransferase /methylenetetrahydrofolate Reductase Genes and Cognition in Late‐onset Depression

Genetic Polymorphism in Catechol‐o‐methyltransferase Associated with the Functional Connectivity of Frontostriatal Circuits in First Episode Schizophrenia Patients

Genetic Contribution of Catechol-O-methyltransferase in Dorsolateral Prefrontal Cortex Functional Changes in the First Episode Schizophrenia

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

[Methylation of the Reelin Gene Promoter in Peripheral Blood and Its Relationship with the Cognitive Function of Schizophrenia Patients]

Association of Catechol-O-Methyltransferase Gene Polymorphisms with Schizophrenia and Negative Symptoms in A Chinese Population

Serotonin transporter gene promoter methylation in peripheral cells in healthy adults: Neural correlates and tissue specificity

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

Serotonin transporter promoter methylation in peripheral cells and neural responses to negative stimuli: A study of adolescent monozygotic twins

Neuropsychological Dysfunctions in Siblings Discordant for Schizophrenia

Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

DNA Methylation and Gene Expression of the Chemokine (C-X-C Motif) Ligand 1 in Patients with Deficit and Non-Deficit Schizophrenia.

Neurocognitive and Clinical Dysfunction in Adult Chinese, Nonpsychotic Relatives of Patients with Schizophrenia: Findings from the Changsha Study and Evidence for Schizotaxia.